# Myles Wolf

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/myles-wolf/

## Facts

| Field | Value |
| --- | --- |
| Citations | 36,445 |
| Field | Parathyroid Disorders and Treatments |
| h-index | 93 |
| i10-index | 245 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5008906136 |
| ORCID iD | https://orcid.org/0000-0002-1127-1442 |
| Works | 367 |

## Researcher papers

Showing 12 of 15.

- [Vitamin D Deficiency and Risk of Cardiovascular Disease](https://scholariq.org/papers/vitamin-d-deficiency-and-risk-of-cardiovascular-disease/)
- [FGF23 induces left ventricular hypertrophy](https://scholariq.org/papers/fgf23-induces-left-ventricular-hypertrophy/)
- [Common genetic determinants of vitamin D insufficiency: a genome-wide association study](https://scholariq.org/papers/common-genetic-determinants-of-vitamin-d-insufficiency-a-genome-wide-association/)
- [Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease](https://scholariq.org/papers/fibroblast-growth-factor-23-is-elevated-before-parathyroid-hormone-and-phosphate/)
- [Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy](https://scholariq.org/papers/survival-of-patients-undergoing-hemodialysis-with-paricalcitol-or-calcitriol/)
- [Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States](https://scholariq.org/papers/prevalence-of-cardiovascular-risk-factors-and-the-serum-levels-of-25/)
- [Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease](https://scholariq.org/papers/fibroblast-growth-factor-23-and-left-ventricular-hypertrophy-in-chronic-kidney/)
- [Activated Injectable Vitamin D and Hemodialysis Survival](https://scholariq.org/papers/activated-injectable-vitamin-d-and-hemodialysis-survival/)
- [Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy](https://scholariq.org/papers/activation-of-cardiac-fibroblast-growth-factor-receptor-4-causes-left/)
- [Fibroblast Growth Factor-23 and Cardiovascular Events in CKD](https://scholariq.org/papers/fibroblast-growth-factor-23-and-cardiovascular-events-in-ckd/)
- [Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease](https://scholariq.org/papers/coronary-artery-calcification-and-risk-of-cardiovascular-disease-and-death-among/)
- [Fibroblast growth factor 23 is not associated with and does not induce arterial calcification](https://scholariq.org/papers/fibroblast-growth-factor-23-is-not-associated-with-and-does-not-induce-arterial/)

## Researcher topics

- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Magnesium in Health and Disease](https://scholariq.org/topics/magnesium-in-health-and-disease/)
- [Vitamin D Research Studies](https://scholariq.org/topics/vitamin-d-research-studies-2/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.